{"mainPropery":{"diseaseId":1049,"diseaseName":"CADASIL","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/1049/cadasil","synonyms":["Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy","Dementia, hereditary multi-infarct type","Familial vascular leukoencephalopathy","Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy","CASIL"],"synonyms-with-source":[{"name":"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy"},{"name":"Dementia, hereditary multi-infarct type"},{"name":"Familial vascular leukoencephalopathy"},{"name":"Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy"},{"name":"CASIL"}],"identifiers":[{"identifierType":"OMIM","identifierId":"125310"},{"identifierType":"ORPHANET","identifierId":"136"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":195,"resourceName":"United Leukodystrophy Foundation","abbreviation":"ULF","address1":"224 North Second Street","address2":"Suite 2","address3":"","address4":"","address5":"","city":"DeKalb","state":"IL","zip":"60115 ","country":"United States","phone":"+1-815-748-3211 ","tty":"","tollFree":"1-800-728-5483","fax":"+1-815-748-0844","email":"office@ulf.org","url":"https://ulf.org/","freeText":""},{"resourceID":448,"resourceName":"CADASIL-Together We Have Hope","abbreviation":"","address1":"3605 Monument Drive","address2":"","address3":"","address4":"","address5":"","city":"Round Rock","state":"TX","zip":"78681-3707","country":"","phone":"512-255-0209","tty":"","tollFree":"877-519-HOPE","fax":"","email":"info@cadasilfoundation.org","url":"http://cadasilfoundation.org/ "},{"resourceID":2219,"resourceName":"Alex The Leukodystrophy Charity","abbreviation":"Alex TLC","address1":"45 Peckham High Street","address2":"","address3":"","address4":"","address5":"","city":"London","state":"","zip":"SE15 5EB","country":"United Kingdom","phone":" 020 7701 4388","tty":"","tollFree":"","fax":"","email":"info@alextlc.org","url":"https://www.alextlc.org","freeText":""},{"resourceID":3257,"resourceName":"cure CADASIL Association","abbreviation":"","address1":"10 Schalks Crossing Road","address2":"Suite 501A-133","address3":"","address4":"","address5":"","city":"Plainsboro","state":"NJ","zip":"08536","country":"United States","phone":"+1-307-215-9840","tty":"","tollFree":"","fax":"","email":"info@cureCADASIL.org","url":"https://curecadasil.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/125310' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed?term=cadasil%5BTitle%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss CADASIL. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22CADASIL%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to CADASIL. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=cadasil' target='_blank'>Genetics Home Reference (GHR)</a> contains information on CADASIL. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1272305' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/cadasil/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/All-Disorders/CADASIL-Information-Page' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1423170-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=136' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=cadasil' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1705,"resourceId":2846,"resourceName":"Project OrphanAnesthesia","descriptionText":"<a href='https://www.orpha.net/data/patho/Ans/en/CADASIL.pdf' target='_blank'>Project OrphanAnesthesia</a> is a project whose aim is to create peer-reviewed, readily accessible guidelines for patients with rare diseases and for the anesthesiologists caring for them. The project is a collaborative effort of the German Society of Anesthesiology and Intensive Care, Orphanet, the European Society of Pediatric Anesthesia, anesthetists and rare disease experts with the aim to contribute to patient safety.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:125310' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":4227,"questionText":"What is CADASIL?","answerText":"<strong>CADASIL (Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy)</strong> is an inherited disease of the blood vessels that occurs when the thickening of blood vessel walls blocks the flow of blood to the brain. The disease primarily affects the small blood vessels in the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002344.htm\" target=\"_blank\">white matter</a>&nbsp;of the brain. CADASIL is characterized by <a href=\"http://www.nlm.nih.gov/medlineplus/migraine.html\" target=\"_blank\">migraine</a>&nbsp;headaches and multiple <a href=\"http://www.nlm.nih.gov/medlineplus/stroke.html\" target=\"_blank\">strokes</a>, which progresses to <a href=\"http://www.nlm.nih.gov/medlineplus/dementia.html\" target=\"_blank\">dementia</a>. Other symptoms include white matter lesions throughout the brain, cognitive deterioration, <a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=\"_blank\">seizures</a>, vision problems, and psychiatric problems such as severe depression and changes in behavior and personality. Individuals may also be at higher risk of heart attack. Symptoms and disease onset vary widely, with signs typically appearing in the mid-30s. Some individuals may not show signs of the disease until later in life.[3168] <br />\r\n<br />\r\nCADASIL is caused by a variant (or <a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/genemutation\" target=\"_blank\">mutation</a>) in a gene called <em><a href=\"http://ghr.nlm.nih.gov/gene/NOTCH3\" target=\"_blank\">NOTCH3</a>.&nbsp;</em>&nbsp;Inheritance is&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>.[3168][3169] There is no cure yet. Treatment is only supportive and depends on the symptoms.[3168][8438]&nbsp;Most people with CADASIL become bed-ridden and develop dementia over time.&nbsp; Life expectancy is also reduced in people with CADASIL due, especially, to lung and heart diseases. Because people who smoke or have high arterial pressure or have other vascular risk factors, control of any vascular risk factors is an important part of CADASIL management.[8438][14695][14696]","dateModified":"2018-06-04T00:00:00"},"basicQuestions":[{"questionId":4228,"questionText":"What are the signs and symptoms of CADASIL?","answerText":"The most common&nbsp; signs and symptoms of CADASIL are &nbsp;caused by damage to small blood vessels, especially those within the brain and include: stroke, <span>&nbsp;</span>cognitive impairment, <span>&nbsp;</span>migraine with aura, and <span>&nbsp;</span>psychiatric disturbances. These symptoms are:[3170]&nbsp;<br />\r\n<ul>\r\n    <li>Recurrent ischemic strokes (transient ischemic attack/stroke) in adulthood that may lead to severe disability&nbsp;such as an inability to walk and&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/urinaryincontinence.html\" target=\"_blank\">urinary incontinence</a>. The average age at onset for stroke-like episodes is 46 years. Transient ischemic attacks and stroke are reported in approximately 85% of symptomatic individuals&nbsp;<strong></strong></li>\r\n    <li>Progressive cognitive decline with&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/dementia.html\" target=\"_blank\">dementia</a>&nbsp;developing in about 75% of affected people including significant difficulty with reasoning and memory</li>\r\n    <li>Migraine, usually with aura, as the first symptom in the third decade of life</li>\r\n    <li>Psychiatric problems such as mood disturbances (apathy and depression), presenting in about 30% of people with CADASIL&nbsp;</li>\r\n    <li>Seizures with&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/epilepsy.html\" target=\"_blank\">epilepsy</a>&nbsp;is present in 10% of affected people and usually presents at middle age</li>\r\n    <li>Diffuse white matter lesions and subcortical infarcts on neuroimaging.</li>\r\n</ul>\r\nLess common signs and symptoms may include:[14696]&nbsp;<br />\r\n<ul style=\"list-style-type: disc;\">\r\n    <li>Other psychiatric issues such as gambling, a seizure lasting 30 minutes or longer, or a cluster of shorter seizures for 30 minutes or more with little or no recovery between episodes (recurrent status epilecticus), psychosis, and bipolar disease</li>\r\n    <li>Slow movements and tremors (parkisionism)</li>\r\n    <li>Memory loss (amnesia)</li>\r\n    <li>Dysfunction of one or more peripheral nerves, typically causing numbness or weakness (neuropathy) </li>\r\n    <li>Muscular weakness due to a muscular disease (myopathy) </li>\r\n    <li><span>Confusion, fever and coma (CADASIL coma)</span></li>\r\n    <li>Acute vestibular syndrome ( rapid onset (over seconds to hours) of vertigo, nausea/vomiting, and abnormal gait  in association with head-motion intolerance and abnormal eye movements, lasting days to weeks)</li>\r\n    <li>Spinal cord involvement.</li>\r\n</ul>\r\n<br />\r\n<br />","dateModified":"2018-06-04T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":3170,"authors":"Rutten J & Lesnik Oberstein SAJ","articleTitle":"CADASIL","bookWebsiteJournalTitle":"GeneReviews","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1500/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14696,"authors":"Donato ID, Bianchi S, Stefano N & cols","articleTitle":"Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects","bookWebsiteJournalTitle":"BMC Medicine","date":"February 24, 2017","volume":"15:41","pages":"","url":"https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0778-8#Sec14","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4666,"questionText":"What causes CADASIL?","answerText":"CADASIL is caused by a variant (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>) in the <span class=\"geneSymbol\"><a href=\"http://ghr.nlm.nih.gov/gene/NOTCH3\" target=\"_blank\"><em>NOTCH3</em></a></span> gene. The <span class=\"geneSymbol\"><em>NOTCH3</em></span> gene gives the body instructions to make the Notch3 receptor <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a>, needed for normal function and survival of vascular smooth muscle cells. Mutations in <em>NOTCH3</em>&nbsp;cause the body to make an abnormal protein, thus impairing the function and survival of vascular smooth muscle cells and causing these cells to self-destruct. The loss of vascular smooth muscle cells in the brain causes blood vessel damage that leads to the characteristic features of CADASIL.[3169]","dateModified":"2018-06-04T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":3169,"authors":"","articleTitle":"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"May 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/cerebral-autosomal-dominant-arteriopathy-with-subcortical-infarcts-and-leukoencephalopathy","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4667,"questionText":"How is CADASIL inherited?","answerText":"CADASIL is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. This means that having a <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a> in only one copy of the responsible gene in each cell is enough to cause CADASIL. In most cases, an affected person inherits the mutated gene from an affected parent. In rare cases, CADASIL may result from having a new mutation in the gene, in which case it is not inherited from a parent.[3169]<br />\r\n<br />\r\nWhen a person with an autosomal dominant condition has children, each child has a 50% (1 in 2) chance to inherit the mutated copy of the gene.[3169]","dateModified":"2018-06-04T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":3169,"authors":"","articleTitle":"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"May 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/cerebral-autosomal-dominant-arteriopathy-with-subcortical-infarcts-and-leukoencephalopathy","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4230,"questionText":"How might CADASIL be treated?","answerText":"There is no cure or effective treatment for CADASIL yet. While <a href=\"https://www.texasheart.org/heart-health/heart-information-center/topics/antiplatelet-therapy/\" target=\"_blank\">antiplatelet treatment</a> is often used, it is also not proven to be useful and some professionals do not recommend using these because microbleeds in the brain may occur in people with CADASIL, and, for this reason, the safety of antiplatelet drugs in this disease is still unknown.[14696][3170]&nbsp;<br />\r\n<br />\r\nMigraine should be treated both symptomatically and prophylactically (with preventative methods), depending on the frequency of symptoms. Some medication that have shown some efficacy in some studies, but have not being proven may include <a href=\"https://medlineplus.gov/druginfo/meds/a682756.html\" target=\"_blank\">acetazolamide</a>, and <a href=\"https://www.epilepsysociety.org.uk/sodium-valproate\" target=\"_blank\">sodium valproate</a> for the migraine, and&nbsp;<a href=\"https://medlineplus.gov/druginfo/meds/a697032.html\" target=\"_blank\">acetylcholinesterase inhibitor </a>for cognitive decline.[14696]<br />\r\n<br />\r\nWhen hypertension, diabetes or hypercholesterolemia (high cholesterol) are also present, they should be treated. Supportive care, including practical help, emotional support, and counseling, is useful for affected people and their families.[14696][3170]<br />\r\n<br />\r\nYearly follow up by a neurologist with expertise in CADASIL is recommended from the time of diagnosis, as well as other specialists as needed.[3170]<br />\r\n<br />\r\nSmoking, angiography, anticoagulants and <a href=\"https://vascular.org/patient-resources/vascular-treatments/thrombolytic-therapy\" target=\"_blank\">thrombolytic therapy</a> are all to be avoided by those with CADASIL as they increase the risk of strokes and/or brain bleeding.[14696]<br />\r\n<br />","dateModified":"2018-06-04T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":3170,"authors":"Rutten J & Lesnik Oberstein SAJ","articleTitle":"CADASIL","bookWebsiteJournalTitle":"GeneReviews","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1500/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14696,"authors":"Donato ID, Bianchi S, Stefano N & cols","articleTitle":"Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects","bookWebsiteJournalTitle":"BMC Medicine","date":"February 24, 2017","volume":"15:41","pages":"","url":"https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0778-8#Sec14","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4229,"questionText":"What is the long-term outlook for people with CADASIL?","answerText":"Symptoms of CADASIL usually progress slowly. By age 65, most people have severe cognitive problems and dementia. Some people lose the ability to walk, and most become completely dependent on the care of others due to multiple strokes.[3168] Life expectancy in people with CADASIL is reduced, mainly because of lung or heart problems.[14695][14696]","dateModified":"2018-06-04T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":3168,"authors":"","articleTitle":"NINDS CADASIL Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke (NINDS)","date":"2017","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/cadasil/CADASIL.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14695,"authors":"","articleTitle":"CADASIL","bookWebsiteJournalTitle":"Orphanet","date":"2013","volume":"","pages":"","url":"https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=136","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14696,"authors":"Donato ID, Bianchi S, Stefano N & cols","articleTitle":"Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects","bookWebsiteJournalTitle":"BMC Medicine","date":"February 24, 2017","volume":"15:41","pages":"","url":"https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0778-8#Sec14","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":6895,"relatedDiseaseName":"Leukodystrophy","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":53550,"abbreviatedInquiry":"Both my grandfather and my uncle died from strokes caused by CADASIL and MS. My father was tested and does not have it. What are the chances that it may have passed him and I will have it?","caseQuestions":[{"questionId":4667,"questionText":"How is CADASIL inherited?","answerText":"CADASIL is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. This means that having a <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a> in only one copy of the responsible gene in each cell is enough to cause CADASIL. In most cases, an affected person inherits the mutated gene from an affected parent. In rare cases, CADASIL may result from having a new mutation in the gene, in which case it is not inherited from a parent.[3169]<br />\r\n<br />\r\nWhen a person with an autosomal dominant condition has children, each child has a 50% (1 in 2) chance to inherit the mutated copy of the gene.[3169]","dateModified":"2018-06-04T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":3169,"authors":"","articleTitle":"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"May 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/cerebral-autosomal-dominant-arteriopathy-with-subcortical-infarcts-and-leukoencephalopathy","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9552,"questionText":"Can CADASIL skip a generation?","answerText":"CADASIL is thought to have 100% <a href=\"http://www.geneticseducation.nhs.uk/genetic-glossary/221-penetrance\" target=\"_blank\">penetrance</a>.[9816] This means that all people who inherit the mutated gene responsible for CADASIL will be affected. However, the age of onset, severity of symptoms, and progression of the disease varies. Likewise, those who do not inherit the mutated gene will not be affected.<br />\r\n<br />\r\nMost people diagnosed with CADASIL have an affected parent. However, the family history may <em>appear</em> to be negative because of failure to recognize symptoms in family members, early death of an affected parent before the onset of symptoms, or late onset of the disease in the affected parent.[9816]<br />\r\n<br />\r\nIf molecular genetic testing has identified the specific mutation present in the <em>NOTCH3</em> gene in an affected family member, testing of at-risk, asymptomatic adult relatives is possible.\r\n<ul>\r\n    <li><em>If the son or daughter of an affected person with an identified mutation is tested and is not found to have the mutation, they will be unaffected and also are not at risk to pass the mutation on to their children or (grandchildren).&nbsp;</em>This means that CADASIL cannot skip a generation; the mutation would not \"reappear\" in a future generation once it has not been passed down.</li>\r\n    <li>If a family member does have the mutation and is asymptomatic, while they will become affected at some point, genetic testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression.[9816]</li>\r\n</ul>\r\nIn a family with an established diagnosis of CADASIL, testing is appropriate to consider in symptomatic people regardless of age. However, testing of asymptomatic people who are younger than 18 years who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate.[9816]<br />\r\n<br />\r\n<a href=\"http://www.nlm.nih.gov/medlineplus/geneticcounseling.html\" target=\"_blank\">Genetic counseling</a> is strongly recommended for people considering genetic testing for a family history of CADASIL.","dateModified":"2015-10-19T11:08:00","references":[{"referenceId":9816,"authors":"Julie Rutten and Saskia AJ Lesnik Oberstein","articleTitle":"CADASIL","bookWebsiteJournalTitle":"GeneReviews","date":"February 26, 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1500/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2567,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by  the <a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>&nbsp;and the&nbsp;<a href=\"https://www.findageneticcounselor.com/\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also <a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a> from Genetics Home Reference.","dateModified":"2017-12-06T00:00:00","references":[]}]},{"caseId":50253,"abbreviatedInquiry":"I was diagnosed with multiple sclerosis (MS) after a spinal tap and MRI. My neurologist ordered genetic testing of NOTCH3, which was positive for CADASIL.  Is it possible to have MS and CADASIL? Also, would CADASIL cause lesions on the brain?","caseQuestions":[{"questionId":8388,"questionText":"Is it possible to have multiple sclerosis and CADASIL?","answerText":"Theoretically, it is possible for an individual to develop both multiple sclerosis and CADASIL. &nbsp;However, because both conditions are uncommon, it would be extremely unlikely to have both. &nbsp;It is more likely that an individual has only one of these conditions. &nbsp;The two conditions can cause similar symptoms, such as changes in brain tissue (lesions) shown on <a href=\"http://www.nlm.nih.gov/medlineplus/mriscans.html\" target=\"_blank\">magnetic resonance imaging (MRI)</a>, which can complicate the process of arriving at the correct diagnosis.[3623][8437][8438] &nbsp;<br />\r\n<br />\r\nArticles in the medical literature mention that MS is the most common misdiagnosis for individuals with CADASIL.[8439] &nbsp;Several tests may help to clarify which diagnosis is correct: the finding of a <a href=\"http://ghr.nlm.nih.gov/gene/NOTCH3\" target=\"_blank\">NOTCH3</a> <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a> on genetic testing is considered diagnostic of CADASIL; the finding of certain proteins in <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003428.htm\" target=\"_blank\">cerebral spinal fluid from a spinal tab</a>&nbsp;may help establish a diagnosis of MS.[8437][8438]<br />","dateModified":"2015-03-03T21:21:00","references":[{"referenceId":3623,"authors":"Rutten J, Lesnik Oberstein SAJ","articleTitle":"CADASIL","bookWebsiteJournalTitle":"GeneReviews","date":"2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1500/","dateAccessed":"2015-03-03T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8437,"authors":"Luzzio C","articleTitle":"Multiple sclerosis","bookWebsiteJournalTitle":"Medscape Reference","date":"2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1146199-overview","dateAccessed":"2015-03-03T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8438,"authors":"Behrouz R","articleTitle":"CADASIL (Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy)","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1423170","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8439,"authors":"Kalman B, Leist TP","articleTitle":"Familial multiple sclerosis and other inherited disorders of the white matter","bookWebsiteJournalTitle":"Neurologist","date":"2004","volume":"10(4)","pages":"201-215","url":"http://www.ncbi.nlm.nih.gov/pubmed/15245586","dateAccessed":"2015-03-03T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8389,"questionText":"Can CADASIL cause lesions in the brain?","answerText":"Yes. &nbsp;CADASIL can cause changes (lesions) in the brain. &nbsp;CADASIL affects the arteries in the brain, causing them to narrow or break down. &nbsp;This affects the flow of blood to the brain, reducing the amount of oxygen which is delivered, which can damage brain tissue over time. &nbsp;Damaged tissue could appear as a lesion on a <a href=\"http://www.nlm.nih.gov/medlineplus/mriscans.html\" target=\"_blank\">magnetic resonance imaging (MRI)</a> test.[3623][8438]","dateModified":"2015-03-03T21:50:00","resourceClassificationName":"Cause","references":[{"referenceId":3623,"authors":"Rutten J, Lesnik Oberstein SAJ","articleTitle":"CADASIL","bookWebsiteJournalTitle":"GeneReviews","date":"2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1500/","dateAccessed":"2015-03-03T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8438,"authors":"Behrouz R","articleTitle":"CADASIL (Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy)","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1423170","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":31060,"abbreviatedInquiry":"My mother and her identical twin sister have CADASIL. While some of my cousins have the condition, I do not. Am I at risk to inherit this condition?&nbsp;","caseQuestions":[{"questionId":4666,"questionText":"What causes CADASIL?","answerText":"CADASIL is caused by a variant (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>) in the <span class=\"geneSymbol\"><a href=\"http://ghr.nlm.nih.gov/gene/NOTCH3\" target=\"_blank\"><em>NOTCH3</em></a></span> gene. The <span class=\"geneSymbol\"><em>NOTCH3</em></span> gene gives the body instructions to make the Notch3 receptor <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a>, needed for normal function and survival of vascular smooth muscle cells. Mutations in <em>NOTCH3</em>&nbsp;cause the body to make an abnormal protein, thus impairing the function and survival of vascular smooth muscle cells and causing these cells to self-destruct. The loss of vascular smooth muscle cells in the brain causes blood vessel damage that leads to the characteristic features of CADASIL.[3169]","dateModified":"2018-06-04T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":3169,"authors":"","articleTitle":"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"May 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/cerebral-autosomal-dominant-arteriopathy-with-subcortical-infarcts-and-leukoencephalopathy","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4667,"questionText":"How is CADASIL inherited?","answerText":"CADASIL is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. This means that having a <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a> in only one copy of the responsible gene in each cell is enough to cause CADASIL. In most cases, an affected person inherits the mutated gene from an affected parent. In rare cases, CADASIL may result from having a new mutation in the gene, in which case it is not inherited from a parent.[3169]<br />\r\n<br />\r\nWhen a person with an autosomal dominant condition has children, each child has a 50% (1 in 2) chance to inherit the mutated copy of the gene.[3169]","dateModified":"2018-06-04T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":3169,"authors":"","articleTitle":"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"May 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/cerebral-autosomal-dominant-arteriopathy-with-subcortical-infarcts-and-leukoencephalopathy","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4668,"questionText":"If a parent has CADASIL, are his or her children at risk to inherit the condition?","answerText":"Every child of an individual with one&nbsp;<em>NOTCH3</em> mutation has a 50% (1 in 2) chance of inheriting the mutation.[3623]","dateModified":"2014-06-05T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":3623,"authors":"Rutten J, Lesnik Oberstein SAJ","articleTitle":"CADASIL","bookWebsiteJournalTitle":"GeneReviews","date":"2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1500/","dateAccessed":"2015-03-03T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":8343,"phenoTypeName":"Lacunar stroke","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11430,"phenoTypeName":"Leukoencephalopathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13967,"phenoTypeName":"Multifocal hyperintensity of cerebral white matter on MRI","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14134,"phenoTypeName":"Apathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13710,"phenoTypeName":"Migraine with aura","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4747,"phenoTypeName":"Mood changes","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11415,"phenoTypeName":"Transient ischemic attack","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14132,"phenoTypeName":"Anxiety","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14785,"phenoTypeName":"Bradyphrenia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2466,"phenoTypeName":"Brain atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10646,"phenoTypeName":"Cerebral hemorrhage","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9380,"phenoTypeName":"Confusion","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6020,"phenoTypeName":"Dementia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6011,"phenoTypeName":"Depressivity","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14182,"phenoTypeName":"Diabetes mellitus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9387,"phenoTypeName":"Encephalopathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9379,"phenoTypeName":"Gait disturbance","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11396,"phenoTypeName":"Hemiplegia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6027,"phenoTypeName":"Hypertension","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11176,"phenoTypeName":"Impaired visuospatial constructive cognition","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5218,"phenoTypeName":"Language impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8511,"phenoTypeName":"Loss of consciousness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11437,"phenoTypeName":"Memory impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11418,"phenoTypeName":"Motor deterioration","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9388,"phenoTypeName":"Parkinsonism","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2230,"phenoTypeName":"Peripheral neuropathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13084,"phenoTypeName":"Recurrent subcortical infarcts","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8711,"phenoTypeName":"Spasticity","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8177,"phenoTypeName":"Stress urinary incontinence","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9162,"phenoTypeName":"Visual loss","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5157,"phenoTypeName":"Aphasia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6005,"phenoTypeName":"Behavioral abnormality","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5621,"phenoTypeName":"Abnormal electroretinogram","percentRanges":"-"},{"phenoTypeId":10274,"phenoTypeName":"Abnormality of the skin","percentRanges":"-"},{"phenoTypeId":10117,"phenoTypeName":"Abnormality of visual evoked potentials","percentRanges":"-"},{"phenoTypeId":6254,"phenoTypeName":"Adult onset","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":13709,"phenoTypeName":"Migraine","percentRanges":"-"},{"phenoTypeId":10538,"phenoTypeName":"Nonarteritic anterior ischemic optic neuropathy","percentRanges":"-"},{"phenoTypeId":4485,"phenoTypeName":"Pseudobulbar paralysis","percentRanges":"-"},{"phenoTypeId":9386,"phenoTypeName":"Stroke","percentRanges":"-"},{"phenoTypeId":4514,"phenoTypeName":"Subcortical dementia","percentRanges":"-"},{"phenoTypeId":6356,"phenoTypeName":"Urinary incontinence","percentRanges":"-"},{"phenoTypeId":13786,"phenoTypeName":"Varicose veins","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"CADASIL"}